Stock Research: Medacta Group

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

Medacta Group

SWX:MOVE CH0468525222
79
  • Value
    8
  • Growth
    98
  • Safety
    Safety
    46
  • Combined
    52
  • Sentiment
    92
  • 360° View
    360° View
    79
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Medacta Group SA is a Swiss-based medical device company specializing in orthopedic products and surgical techniques. The company operates in joint replacement, spine surgery, and sports medicine, offering hip, knee, shoulder, and spine products. It operates globally, providing training and support to healthcare professionals. In the last fiscal year, the company had a market cap of $3419 million, profits of $414 million, revenue of $611 million, and 1907 employees.

more
Index
SPI
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 2-Feb-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
8 20 13 41
Growth
98 80 99 71
Safety
Safety
46 41 39 37
Sentiment
92 78 77 32
360° View
360° View
79 54 73 35
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
57 69 46 19
Opinions Change
75 84 79 92
Pro Holdings
n/a 65 59 47
Market Pulse
91 57 68 12
Sentiment
92 78 77 32
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
8 20 13 41
Growth
98 80 99 71
Safety Safety
46 41 39 37
Combined
52 45 52 56
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
11 15 16 31
Price vs. Earnings (P/E)
13 21 21 44
Price vs. Book (P/B)
5 6 1 14
Dividend Yield
27 44 43 49
Value
8 20 13 41
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
88 85 75 65
Profit Growth
94 81 91 64
Capital Growth
71 37 56 45
Stock Returns
84 62 91 69
Growth
98 80 99 71
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
42 39 40 26
Refinancing
32 34 31 33
Liquidity
78 75 56 52
Safety Safety
46 41 39 37

Similar Stocks

Discover high‑ranked alternatives to Medacta Group and broaden your portfolio horizons.

Drägerwerk

GER:DRW8
Country: Germany
Industry: Health Care Equipment
Size: Medium
Full Stock Analysis

Bachem

SWX:BANB
Country: Switzerland
Industry: Life Sciences Tools & Services
Size: Medium
Full Stock Analysis

Swatch

VTX:UHR
Country: Switzerland
Industry: Apparel, Accessories, Luxury
Size: X-Large
Full Stock Analysis

Smith & Nephew

LSE:SN.
Country: United Kingdom
Industry: Health Care Equipment
Size: Large
Full Stock Analysis

Frequently Asked
Questions

This stock offers a high growth opportunity with safe financing and positive sentiment. It is typically expensive (low Value Rank), as investors pay a premium for high performance. It is for growth-focused investors comfortable paying a premium for a stock with strong future momentum.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: